T. Rowe Price Associates’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-7,226
Closed -$423K 2551
2020
Q1
$423K Sell
7,226
-535
-7% -$52.4K ﹤0.01% 2057
2019
Q4
$981K Sell
7,761
-351
-4% -$47.5K ﹤0.01% 1893
2019
Q3
$993K Sell
8,112
-2,959
-27% -$596K ﹤0.01% 1831
2019
Q2
$3.31M Sell
11,071
-54
-0.5% -$22.5K ﹤0.01% 1458
2019
Q1
$5.01M Buy
11,125
+19
+0.2% +$8.32K ﹤0.01% 1399
2018
Q4
$5.08M Sell
11,106
-2
-0% -$1.24K ﹤0.01% 1404
2018
Q3
$10.1M Sell
11,108
-5
-0% -$3.3K ﹤0.01% 1370
2018
Q2
$6.52M Sell
11,113
-20
-0.2% -$13.1K ﹤0.01% 1407
2018
Q1
$7.25M Buy
+11,133
New +$8.36M ﹤0.01% 1381

Other funds holding HTGM